跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XIGDUO 5 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
XIGDUO 5 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
XIGDUO 5 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Astrazeneca Ab
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 17, 2020
Approval ID
bfcf4452632d4399
Company
Astrazeneca Ab
Type
Standard
Approval Details
Approval Id
bfcf4452632d4399
Drug Cima Aemps Name
XIGDUO 5 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
13900009IP1
Holder Company Name
Astrazeneca Ab
Marketing Company Name
Melyfarma S.L.
Holder Company Detail Path
/organization/astrazeneca-ab
Authorization Date
2020-09-17
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 mg/1000 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Astrazeneca Ab
Company Detail Path
/organization/astrazeneca-ab
Company Information
Pharmaceutical Company Name
AstraZeneca AB
Name En
AstraZeneca AB
Country Name
Spain
City Name
madrid,madrid,country_es
Address
CALLE RAIMUNDO FERNANDEZ VILLAVERDE 63
Website
http://www.astrazeneca.se
Active Ingredients
DAPAGLIFLOZINA
5 mg
METFORMINA HIDROCLORURO
1000 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 17, 2020
Approval ID
bfcf4452632d4399
Type
Standard
Back to CIMA-AEMPS Approvals